112202 ⎘
Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#2MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#3Oncolytic virus for expression of immune checkpoint modulators
#4MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#5Methods for treating or preventing HBV infection or HBV related diseases
#6Means and methods for treating HBV
#7METHODS AND COMPOSITIONS USING LISTERIA FOR ENHANCING IMMUNOGENICITY BY PRIME BOOST
#8MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#9Virus-based expression vectors and uses thereof
#10HBV polymerase mutants
#11Hendra virus recombinant compositions and uses thereof
#12Methods and compositions using for enhancing immunogenicity by prime boost
#13sporozoite and liver stage antigens
#14MVA vaccine for delivery of a UL128 complex and preventing CMV infection
#15Methods and compositions using listeria for enhancing immunogenicity by prime boost
#16PROMOTERS FOR RECOMBINANT VIRAL EXPRESSION
#17HBV polymerase mutants
#18Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface envelope glycoprotein
#19DIAGNOSTIC ASSAY FOR TRYPANOSOMA CRUZI INFECTION
#20HENDRA VIRUS RECOMBINANT COMPOSITIONS AND USES THEREOF
#21System for generation of viable reovirus from cloned cDNA
#22Promoters for recombinant viral expression
#23Immunogenic composition and use thereof
#24Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
#25Immunogenic peptides and methods of use
#26Immunogenic constructs
#27Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer
#28Plasmodium falciparum sporozoite and liver stage antigens
#29Immunotherapy for Unresectable Pancreatic Cancer
#30Use of MVA to treat prostate cancer
#31Diagnostic assay for infection
#32Methods and compositions using for enhancing immunogenicity by prime boost
#33POLYPEPTIDE
#34Recombinant vaccine against West Nile Virus
#35Immunotherapeutic method
#36Compositions and methods for WT1 specific immunotherapy
#37Immunogenic constructs
#38Modified KSA and Uses Thereof
#39Use of MVA to treat prostate cancer
#40Methods and Compositions for Mycoplasma Toxins
#41Immunogenic peptides and methods of use
#42Method of enhancing a targeted immune response against tumors
#43Materials and methods relating to improved vaccination strategies
#44Compositions for immunizing against mycobacterium
#45In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
#46Modified CEA/B7 vector
#47Polypeptide
#48Polypeptide
#49System for treating and preventing breast cancer
#50Polypeptide
#51Methods of producing a library and methods of selecting polynucleotides of interest
#52Multi-antigen vectors of melanoma
#53Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
#54Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
#55Novel recombinant poxvirus composition and uses thereof
#56Recombinant vaccine against West Nile Virus
#57Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
#58Biological material for preparing pharmaceutical compositions intended for treating mammals
#59In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
#60Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
#61Method of enhancing a targeted immune response against tumors
#62Antibodies that bind to and inhibit human cytochrome P450 2C9*1, 2C9*2, and 2C9*3
#63Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule